Cue Biopharma
49 hedge funds and large institutions have $10.4M invested in Cue Biopharma in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
49
Holding in Top 10
–
Calls
$20K
Puts
$6K
Top Buyers
| 1 | +$237K | |
| 2 | +$69.4K | |
| 3 | +$57K | |
| 4 |
Renaissance Technologies
New York
|
+$33.7K |
| 5 |
Squarepoint
New York
|
+$13.8K |
Top Sellers
| 1 | -$436K | |
| 2 | -$110K | |
| 3 | -$75.5K | |
| 4 |
Jane Street
New York
|
-$69.5K |
| 5 |
HF
HRT Financial
New York
|
-$53K |